New mpox variant identified in England: a worrying development in the ongoing global outbreak.
The UK Health Security Agency (UKHSA) has confirmed the presence of a new variant of mpox in England, which was detected in a person who recently traveled to Asia. Genome sequencing revealed that this strain is a recombinant form, combining elements of two existing types: clade 1, associated with more severe cases, and clade 2, linked to the 2022 global outbreak.
While most mpox infections are mild, health officials are urging eligible individuals to get vaccinated to protect themselves. The UKHSA is continuing to assess the significance of this new strain and warns that it may pose a risk to public health. "It's normal for viruses to evolve," said Dr Katy Sinka, head of sexually transmitted infections at UKHSA, "and further analysis will help us understand more about how mpox is changing."
As the global health situation continues to evolve, the World Health Organization (WHO) has declared a year-long public health emergency over the 2022 outbreak. The emergence of this new strain highlights the ongoing potential for the virus to adapt and change.
With nearly 48,000 confirmed cases worldwide reported in 94 countries as of October 2025 β including 201 deaths β health experts are calling for increased vigilance. The UK has implemented an mpox vaccination programme for eligible groups, but further research is needed to determine the severity of this new strain and its potential impact on public health.
Trudie Lang, a professor of global health research at the University of Oxford, emphasizes that understanding the transmission route, presentation, and severity of disease will be crucial in assessing whether this new strain poses an increased risk. With ongoing genomic surveillance and continued vaccination efforts, health officials are urging caution as the situation continues to unfold.
The UK Health Security Agency (UKHSA) has confirmed the presence of a new variant of mpox in England, which was detected in a person who recently traveled to Asia. Genome sequencing revealed that this strain is a recombinant form, combining elements of two existing types: clade 1, associated with more severe cases, and clade 2, linked to the 2022 global outbreak.
While most mpox infections are mild, health officials are urging eligible individuals to get vaccinated to protect themselves. The UKHSA is continuing to assess the significance of this new strain and warns that it may pose a risk to public health. "It's normal for viruses to evolve," said Dr Katy Sinka, head of sexually transmitted infections at UKHSA, "and further analysis will help us understand more about how mpox is changing."
As the global health situation continues to evolve, the World Health Organization (WHO) has declared a year-long public health emergency over the 2022 outbreak. The emergence of this new strain highlights the ongoing potential for the virus to adapt and change.
With nearly 48,000 confirmed cases worldwide reported in 94 countries as of October 2025 β including 201 deaths β health experts are calling for increased vigilance. The UK has implemented an mpox vaccination programme for eligible groups, but further research is needed to determine the severity of this new strain and its potential impact on public health.
Trudie Lang, a professor of global health research at the University of Oxford, emphasizes that understanding the transmission route, presentation, and severity of disease will be crucial in assessing whether this new strain poses an increased risk. With ongoing genomic surveillance and continued vaccination efforts, health officials are urging caution as the situation continues to unfold.